Owning IP is valuable, but licensing and assigning it is often more valuable still — licensing generates revenue without surrendering ownership, while assignment transfers IP assets outright, most commonly in M&A transactions.
Licensing agreements — trademark, patent, copyright, or know-how — can be exclusive (a single licensee, more valuable but more restrictive for the licensor) or non-exclusive (multiple licensees, more revenue but more competition). Key provisions include the grant of rights, territory, field of use, term, royalty structure, minimum royalties, quality control, confidentiality, indemnity, and termination.
Royalty structures vary by industry: software often charges per-user or percentage-of-revenue fees, pharmaceutical licensing typically runs 10-15% of net sales, and trademark franchising commonly runs 3-8% of franchisee revenue — appropriate rates depend on IP strength, exclusivity, and the licensee’s margins.
IP assignment transfers ownership outright and is central to M&A. A well-drafted assignment clearly identifies the assets, confirms the assignor’s ownership and authority, addresses treatment of future improvements, and includes representations, warranties, and indemnities protecting the assignee against invalidity or third-party claims.
IP licensing agreement drafting covering trademark, patent, copyright, and trade secret licenses
Negotiation and term sheets for licensing transactions balancing both parties’ interests
IP assignment and purchase agreements for M&A transactions and IP monetisation
Registration and transfer of IP rights with relevant authorities following licensing or assignment
Royalty audit provisions and enforcement to ensure licensees comply with payment obligations
Who this applies to: IP-rich companies monetising patents, trademarks, or copyrights through licensing; technology companies licensing software or know-how internationally; pharmaceutical firms licensing discoveries to manufacturers; brand owners operating franchising models; acquirers requiring IP assignment documentation.
See also: IP Due Diligence · Patent Registration & Advisory.
Can't find your answer? Our team responds to every enquiry within one business day.
Ask a questionThis page is provided for general information only and does not constitute legal advice. Law references last reviewed July 2026.
Confidential, and free for your first review.
Call the firm+971 50 887 2523Email usinfo@abrlaw.comWhatsAppChat with our team